Side-by-side financials for CTSO and MDLN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CTSO | MDLN |
|---|---|---|
| Market cap | - | $49.12 B |
| US-listed rank | - | #330 |
| Revenue (latest FY) | $37.06M | $28.43B |
| Net income (latest FY) | -$8.20M | $1.16T |
| Net margin | -22.1% | 4069.4% |
| P/E (trailing FY) | - | 0.0 |
| SEC filings | 959 | 103 |
In their latest fiscal years, Cytosorbents Corp reported $37.06M in revenue while Medline Inc. reported $28.43B.
Full pages: Cytosorbents Corp and Medline Inc., or browse the full rankings.